Search For "vaccine"
Putin compares nature of COVID-induced global economic crisis to Great Dep
Updated : 5 years, 4 months ago IST
Riyadh [Saudi Arabia], November 21 (ANI): Russian President Vladimir Putin on Saturday at the G20 summit called the economic crisis caused by the ongoing COVID-19 pandemic 'a major world crisis' since the Great Depression.
Read More
Macron calls for distributing first COVID-19 vaccine doses to low-income c
Updated : 5 years, 4 months ago IST
Paris [France], November 21 (ANI/Sputnik): French President Emmanuel Macron told the G20 summit on Saturday that the world's leading economies should join efforts to create a system that envisions disturbing first doses of potential coronavirus vaccines to least developed countries.
Read More
COVID-19: Phase 3 of COVAXIN to check its effectiveness to prevent disease
Updated : 5 years, 4 months ago IST
Bhubaneswar (Odisha) [India], November 21 (ANI): In phase 3, COVAXIN's effectiveness to prevent the disease (coronavirus) will be checked, said Dr. E Venkata Rao, Principal investigator of COVAXIN trial at Institute of Medical Sciences and SUM Hospital, Bhubaneswar, while adding that out
Read More
Philippines logs 1,791 new COVID-19 cases, Duterte calls for universal vac
Updated : 5 years, 4 months ago IST
Manila [Philippines], November 21 (ANI/Xinhua): The Department of Health (DOH) of the Philippines on Saturday reported 1,791 new confirmed cases of COVID-19 infection, bringing the total number in the country to 416,852.
Read More
Saudi Arabia commits USD 500mln to COVID-19 vaccine development
Updated : 5 years, 4 months ago IST
Riyadh [Saudi Arabia], November 21 (ANI/Sputnik): The Saudi Arabian government has committed more than $500 million to funding efforts to develop and produce a safe and effective vaccine against the coronavirus disease, the country's health minister, Tawfig Al Rabiah, said ahead of the G20 S
Read More
PM Modi reviews India's COVID-19 vaccination strategy
Updated : 5 years, 4 months ago IST
New Delhi [India], November 20 (ANI): Prime Minister Narendra Modi on Friday held a meeting to review the country's vaccination strategy in which important issues related to progress of COVID-19 vaccine development, regulatory approvals and procurement were discussed.
Read More
Pfizer, BioNTech to submit to FDA for emergency use authorisation for thei
Updated : 5 years, 4 months ago IST
Washington [US], November 20 (ANI): American drug giant Pfizer and German laboratory BioNTech on Friday said that they will be submitting to the US Food and Drug Administration for emergency use authorisation for their COVID-19 vaccine candidate.
Read More
Engineered immune cells, new hope for HIV vaccine: Research
Updated : 5 years, 4 months ago IST
Washington [US], November 20 (ANI): Scientists at Scripps Research have moved closer to attaining a triumph over HIV research with a new vaccine approach that would anticipate engineered immune cells from the patient's body.
Read More
Haryana Health Minister Anil Vij administered trial dose of Covaxin
Updated : 5 years, 4 months ago IST
Ambala (Haryana) [India], November 20 (ANI): Haryana Health Minister Anil Vij was administered a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' at a hospital in Ambala on Friday.
Read More
Indian airlines, airports are all set to handle distribution of temperatur
Updated : 5 years, 4 months ago IST
New Delhi [India], November 20 (ANI): As some of the coronavirus vaccine trials across the world are in their final stages, Indian airports and airlines have geared up to to handle the distribution of temperature-sensitive vaccines in the country.
Read More
Oxford University Covid-19 vaccine "well tolerated in older adults"
Updated : 5 years, 4 months ago IST
New Delhi [India], November 19 (ANI): Major drug marker Serum of Institute of India (SII) on Thursday said that the coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years
Read More
UK's Oxford vaccine phase-2 trial indicates strong results in older adults
Updated : 5 years, 4 months ago IST
New Delhi [India], November 19 (ANI): In a major development, UK's Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial.
Read More